Cutaneous leishmaniasis and 500 000 for visceral leishmaniasis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Skin Spleen Macrophages Th1 Cells Bone Marrow Leukocytes, Mononuclear T-Lymphocytes Lymph Nodes Ear, External

Organisms21

Leishmania Leishmania infantum Leishmania donovani Leishmania braziliensis Psychodidae Leishmania tropica Phlebotomus Leishmania guyanensis Leishmania major Leishmania mexicana Dogs Mice, Inbred BALB C Hyraxes Mesocricetus Rodentia Perissodactyla Cricetinae Life Cycle Stages Achillea Calophyllum Mice, Inbred C57BL

Diseases25

Leishmaniasis, Visceral Leishmaniasis, Cutaneous Leishmaniasis Leishmaniasis, Mucocutaneous Leishmaniasis, Diffuse Cutaneous Dog Diseases Skin Ulcer Zoonoses Asymptomatic Infections Insect Bites and Stings Hypersensitivity, Delayed Facial Dermatoses AIDS-Related Opportunistic Infections Eyelid Diseases Euglenozoa Infections Emaciation Neglected Diseases Disease Models, Animal Coinfection Liver Diseases, Parasitic Erysipeloid Chagas Disease Granuloma Leprosy, Lepromatous Disease Susceptibility

Chemicals and Drugs32

Antiprotozoal Agents Meglumine Antimony Antimony Sodium Gluconate Leishmaniasis Vaccines Antigens, Protozoan Paromomycin Antibodies, Protozoan Organometallic Compounds Phosphorylcholine DNA, Protozoan DNA, Kinetoplast Protozoan Vaccines Amphotericin B Pentamidine Benzethonium Protozoan Proteins Interferon-gamma Trypanocidal Agents Interleukin-10 Aminoquinolines Immunoglobulin G Insecticides DNA, Ribosomal Spacer Interleukin-4 Cytokines Ointments Pyrethrins Interleukin-12 Allopurinol Liposomes Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment21

Parasite Load Skin Tests Sensitivity and Specificity Polymerase Chain Reaction Serologic Tests Agglutination Tests Enzyme-Linked Immunosorbent Assay Immunochromatography Parasitic Sensitivity Tests Intradermal Tests Fluorescent Antibody Technique, Indirect Treatment Outcome Disease Models, Animal Incidence Administration, Topical Cryotherapy Drug Therapy, Combination Biopsy Injections, Intramuscular Lymphocyte Activation Administration, Oral

Phenomena and Processes12

Sensitivity and Specificity Seasons Host-Parasite Interactions Immunity, Cellular Life Cycle Stages Drug Resistance Species Specificity Polymorphism, Restriction Fragment Length Climate Disease Susceptibility Time Factors Lymphocyte Activation

Disciplines and Occupations4

Parasitology Geography, Medical Topography, Medical Veterinary Medicine

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture2

Military Facilities Liposomes

Information Science2

Incidence Molecular Sequence Data

Named Groups1

Military Personnel

Health Care15

Insect Vectors Endemic Diseases Disease Reservoirs Insect Control Disease Vectors Sensitivity and Specificity Population Density Seasons Treatment Outcome Incidence Rural Population Urban Population Housing Climate Disease Outbreaks

Geographicals26

Brazil Venezuela Sudan India Colombia Nepal Argentina Tunisia Peru Afghanistan Panama Suriname Iran Ethiopia Bolivia Bangladesh Asia, Central French Guiana Ecuador Morocco Mediterranean Region Sri Lanka USSR Africa, Eastern Syria Turkey

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Leishmaniasis, Visceral Leishmaniasis, Cutaneous Leishmaniasis Antiprotozoal Agents Leishmania Leishmania infantum Leishmania donovani Leishmania braziliensis Leishmaniasis, Mucocutaneous Psychodidae Meglumine Leishmaniasis, Diffuse Cutaneous Leishmania tropica Antimony Phlebotomus Antimony Sodium Gluconate Leishmania guyanensis Leishmaniasis Vaccines Dog Diseases Leishmania major Leishmania mexicana Antigens, Protozoan Paromomycin Antibodies, Protozoan Insect Vectors Organometallic Compounds Endemic Diseases Phosphorylcholine Brazil DNA, Protozoan Parasite Load DNA, Kinetoplast Protozoan Vaccines Amphotericin B Venezuela Disease Reservoirs Insect Control Sudan Dogs India Parasitology Colombia Mice, Inbred BALB C Skin Ulcer Pentamidine Benzethonium Protozoan Proteins Nepal Skin Tests Disease Vectors Hyraxes Sensitivity and Specificity Skin Argentina Polymerase Chain Reaction Zoonoses Population Density Serologic Tests Agglutination Tests Tunisia Interferon-gamma Enzyme-Linked Immunosorbent Assay Peru Afghanistan Immunochromatography Panama Suriname Seasons Mesocricetus Iran Ethiopia Parasitic Sensitivity Tests Intradermal Tests Trypanocidal Agents Interleukin-10 Bolivia Fluorescent Antibody Technique, Indirect Rodentia Military Facilities Geography, Medical Spleen Aminoquinolines Macrophages Asymptomatic Infections Bangladesh Th1 Cells Insect Bites and Stings Asia, Central Immunoglobulin G French Guiana Hypersensitivity, Delayed Ecuador Facial Dermatoses Morocco Perissodactyla AIDS-Related Opportunistic Infections Eyelid Diseases Travel Cricetinae Euglenozoa Infections

No FAQ available that match "cutaneous leishmaniasis and 500 000 for visceral leishmaniasis"